• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经炎和多发性硬化症脑脊液中抗髓鞘碱性蛋白和蛋白脂蛋白自身抗体的相对频率。

Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.

作者信息

Warren K G, Catz I

机构信息

Department of Medicine (Neurology), University of Alberta, Edmonton, Canada.

出版信息

J Neurol Sci. 1994 Jan;121(1):66-73. doi: 10.1016/0022-510x(94)90158-9.

DOI:10.1016/0022-510x(94)90158-9
PMID:7510787
Abstract

Myelin basic protein (MBP) and proteolipid protein (PLP) were purified from non-MS human brain and used in solid phase radioimmunoassays to detect their specific antibodies in cerebrospinal fluid (CSF) of optic neuritis and clinically definite multiple sclerosis (MS) patients. In 53 optic neuritis patients free anti-MBP was elevated in 47 and in 6 of these 47 patients bound anti-MBP was also increased. The remaining 6 patients with undetectable anti-MBP had increased levels of anti-PLP in their CSF. None of these optic neuritis patients had autoantibodies to both antigens. Of 173 MS patients with acute relapses 169 had increased free anti-MBP. Three of the 4 remaining patients with undetectable anti-MBP had increased anti-PLP in their CSF. Of 110 MS patients with chronic progressive disease, 107 had increased CSF anti-MBP and 2 had elevated anti-PLP. Of 87 MS patients in remission, 15 had modestly elevated anti-MBP and none had detectable anti-PLP. Considering the total of 370 clinically definite MS patients with active and inactive disease, 77% had increased CSF anti-MBP and 1% had increased CSF anti-PLP. These findings are suggesting 2 immunochemically distinct forms of MS: a common form with autoantibodies directed against MBP and a more rare form associated with anti-PLP.

摘要

从非多发性硬化症(MS)患者的人脑组织中纯化出髓鞘碱性蛋白(MBP)和蛋白脂蛋白(PLP),并用于固相放射免疫分析,以检测视神经炎和临床确诊的多发性硬化症(MS)患者脑脊液(CSF)中的特异性抗体。在53例视神经炎患者中,47例游离抗MBP升高,其中6例结合抗MBP也升高。其余6例抗MBP检测不到的患者脑脊液中抗PLP水平升高。这些视神经炎患者均无针对两种抗原的自身抗体。在173例急性复发的MS患者中,169例游离抗MBP升高。其余4例抗MBP检测不到的患者中,3例脑脊液中抗PLP升高。在110例慢性进展性疾病的MS患者中,107例脑脊液抗MBP升高,2例抗PLP升高。在87例缓解期的MS患者中,15例抗MBP轻度升高,无抗PLP检测到。考虑到370例临床确诊的MS患者,包括活动期和非活动期,77%的患者脑脊液抗MBP升高,1%的患者脑脊液抗PLP升高。这些发现提示MS存在两种免疫化学上不同的形式:一种常见形式是针对MBP的自身抗体,另一种较罕见的形式与抗PLP有关。

相似文献

1
Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.视神经炎和多发性硬化症脑脊液中抗髓鞘碱性蛋白和蛋白脂蛋白自身抗体的相对频率。
J Neurol Sci. 1994 Jan;121(1):66-73. doi: 10.1016/0022-510x(94)90158-9.
2
Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.多发性硬化症的抗髓鞘碱性蛋白和抗蛋白脂蛋白特异性形式。
Ann Neurol. 1994 Mar;35(3):280-9. doi: 10.1002/ana.410350307.
3
Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid.视神经炎和多发性硬化症中的自身免疫性T细胞库:识别多种髓鞘蛋白的T细胞在脑脊液中积聚。
J Neurol Neurosurg Psychiatry. 1994 May;57(5):544-51. doi: 10.1136/jnnp.57.5.544.
4
Optic neuritis anti-myelin basic protein synthetic peptide specificity.视神经炎抗髓鞘碱性蛋白合成肽特异性。
J Neurol Sci. 1992 May;109(1):88-95. doi: 10.1016/0022-510x(92)90099-7.
5
Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.通过抗原特异性亲和层析从多发性硬化症患者脑脊液IgG中纯化针对髓鞘碱性蛋白的自身抗体。用人髓鞘碱性蛋白进行免疫反应性研究。
J Neurol Sci. 1991 May;103(1):90-6. doi: 10.1016/0022-510x(91)90289-j.
6
T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis.在视神经炎和多发性硬化症中,可在血液中发现识别髓鞘碱性蛋白多种肽段的T细胞,且在脑脊液中富集。
Scand J Immunol. 1993 Mar;37(3):355-68. doi: 10.1111/j.1365-3083.1993.tb02565.x.
7
MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis.髓鞘碱性蛋白、抗髓鞘碱性蛋白和抗髓磷脂蛋白抗体以及多发性硬化症中的鞘内补体激活
Mult Scler. 1998 Jun;4(3):127-31. doi: 10.1177/135245859800400307.
8
Cerebrospinal fluid antibodies to myelin basic protein in acute idiopathic optic neuritis.急性特发性视神经炎患者脑脊液中抗髓鞘碱性蛋白抗体
Ann Neurol. 1988 Mar;23(3):297-9. doi: 10.1002/ana.410230314.
9
Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis.
Arch Neurol. 1994 Oct;51(10):1032-6. doi: 10.1001/archneur.1994.00540220078017.
10
Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.临床缓解期多发性硬化症患者脑脊液对抗髓鞘碱性蛋白的中和作用
J Neurol Sci. 1988 Dec;88(1-3):185-94. doi: 10.1016/0022-510x(88)90216-x.

引用本文的文献

1
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders.中枢神经系统自身免疫性脱髓鞘疾病患者中针对蛋白脂蛋白-1及其外周异构体DM20的构象抗体
Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200359. doi: 10.1212/NXI.0000000000200359. Epub 2025 Jan 17.
2
Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.B 细胞失调和 IgE 抗体应答对多发性硬化症的贡献。
Front Immunol. 2022 Jun 16;13:900117. doi: 10.3389/fimmu.2022.900117. eCollection 2022.
3
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.
多发性硬化症治疗药物对 B 细胞的差异化影响 - 对 AQP4 阳性 NMOSD 患者的应用和失败的启示。
Int J Mol Sci. 2020 Jul 16;21(14):5021. doi: 10.3390/ijms21145021.
4
The role of B cells in the immunopathogenesis of multiple sclerosis.B 细胞在多发性硬化症免疫发病机制中的作用。
Immunology. 2020 Aug;160(4):325-335. doi: 10.1111/imm.13198. Epub 2020 May 10.
5
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.B 细胞和抗体在多发性硬化症、视神经脊髓炎及相关疾病中的作用。
Front Immunol. 2019 Feb 8;10:201. doi: 10.3389/fimmu.2019.00201. eCollection 2019.
6
Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.治疗原发性进行性多发性硬化症:奥瑞珠单抗的潜力及B细胞疗法综述
Degener Neurol Neuromuscul Dis. 2017 Feb 1;7:31-45. doi: 10.2147/DNND.S100096. eCollection 2017.
7
Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.解析多发性硬化症中 B 细胞的作用——针对致病功能的特异性靶向治疗。
Int J Mol Sci. 2017 Sep 23;18(10):2048. doi: 10.3390/ijms18102048.
8
The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.外周中枢神经系统定向抗体在促进炎症性中枢神经系统脱髓鞘中的作用。
Brain Sci. 2017 Jun 22;7(7):70. doi: 10.3390/brainsci7070070.
9
B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.多发性硬化症中针对B细胞的疗法:理论依据与临床证据
CNS Drugs. 2016 Dec;30(12):1137-1148. doi: 10.1007/s40263-016-0396-6.
10
Activated GL7 B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis.在病毒性脑脊髓炎期间,形成滤泡的情况下,激活的 GL7 B 细胞在炎症中枢神经系统内得以维持。
Brain Behav Immun. 2017 Feb;60:71-83. doi: 10.1016/j.bbi.2016.09.022. Epub 2016 Sep 19.